This newest twist while in the Lykos Therapeutics saga threatens a major overhaul of the company’s strategy and course, with Musk ally and billionaire Trader Antonio Gracias showing to want to choose the corporation back again toward its nonprofit drug development roots and a far more Doblinite philosophy.Patent applications are magic formula for